PL385697A1 - Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2, 4-tiazolidynodionu z kwasem 1, 5-naftalenodisulfonowym i sposób jej wytwarzania - Google Patents

Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2, 4-tiazolidynodionu z kwasem 1, 5-naftalenodisulfonowym i sposób jej wytwarzania

Info

Publication number
PL385697A1
PL385697A1 PL385697A PL38569708A PL385697A1 PL 385697 A1 PL385697 A1 PL 385697A1 PL 385697 A PL385697 A PL 385697A PL 38569708 A PL38569708 A PL 38569708A PL 385697 A1 PL385697 A1 PL 385697A1
Authority
PL
Poland
Prior art keywords
methyl
pyridinylamino
thiazolidinedione
ethoxy
phenyl
Prior art date
Application number
PL385697A
Other languages
English (en)
Inventor
Michał Chodyński
Andrzej Kutner
Kinga Leszczyńska
Anita Pietraszek
Magdalena Glice
Katarzyna Korczak
Wioleta Maruszak
Original Assignee
Adamed Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adamed Spółka Z Ograniczoną Odpowiedzialnością filed Critical Adamed Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL385697A priority Critical patent/PL385697A1/pl
Publication of PL385697A1 publication Critical patent/PL385697A1/pl

Links

PL385697A 2008-07-18 2008-07-18 Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2, 4-tiazolidynodionu z kwasem 1, 5-naftalenodisulfonowym i sposób jej wytwarzania PL385697A1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL385697A PL385697A1 (pl) 2008-07-18 2008-07-18 Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2, 4-tiazolidynodionu z kwasem 1, 5-naftalenodisulfonowym i sposób jej wytwarzania

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL385697A PL385697A1 (pl) 2008-07-18 2008-07-18 Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2, 4-tiazolidynodionu z kwasem 1, 5-naftalenodisulfonowym i sposób jej wytwarzania

Publications (1)

Publication Number Publication Date
PL385697A1 true PL385697A1 (pl) 2010-02-01

Family

ID=43012192

Family Applications (1)

Application Number Title Priority Date Filing Date
PL385697A PL385697A1 (pl) 2008-07-18 2008-07-18 Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2, 4-tiazolidynodionu z kwasem 1, 5-naftalenodisulfonowym i sposób jej wytwarzania

Country Status (1)

Country Link
PL (1) PL385697A1 (pl)

Similar Documents

Publication Publication Date Title
PL384446A1 (pl) Sól 5-[[4-[2-(metylo-2-pirydynyloamino)etoksy]fenylo]metylo]-2,4-tiazolidynodionu z kwasem malonowym i sposób jej wytwarzania
IL223002A0 (en) Crystalline form of 4- [5 - [3 -chloro-5 - (trifluoromethyl) phenyl] -4, 5 - dihydro - 5 - (trifluoromethyl) -3 - isoxazolyl] -n- [2-0x0-2- [ ( 2, 2, 2 - trifluoroethyl) amino] ethyl] -1- naphthalenecarboxamide
ZA201003902B (en) Pharmaceutically acceptable salts of 2-{4-[(3s)-piperidin-3-yl]phenyl}-2h-indazole-7-carboxamide
IL220212A (en) Derivatives 5 - [(2-Aminopyrimide-4-Yl) Methylidan] -3,1-Thiazolidine-4,2-Discussion and Pharmaceutical Preparations Containing Them
IL207854A0 (en) Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4]oxadiazol-5-yl]-3-nit robenzene-1,2-diol
IL216349A (en) Annals 4– (1-carboxy-ethylcarbamoyl) –4– (5– [1,12] diethylan-3-ram-pentanoylamino) -butyric acid and preparations containing them
PL2203433T3 (pl) 5-(4-(2-(3-metoksyfenylo)-2-oksoetoksy)benzylo)tiazolidyno-2,4-dion do stosowania w leczeniu cukrzycy
EP1993934A4 (en) PET-CHEWS WITH INTERNAL AND EXTERNAL MATERIALS OF DIFFERENT STIFFNESS
WO2011141933A3 (en) Process for preparation of 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid and its pharmaceutically acceptable salts
PT2344465E (pt) Formas cristalinas de (r)-5-[3-cloro-4-(2,3-dihidroxipropoxi)- benz[z]ilideno]-2-([z]-propilimino)-3-o-toliltiazolidin- 4-ona
ZA200902354B (en) Crystalline forms of thiazolidinedione compound and its manufacturing method
IL267557B (en) Process for the preparation of 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl[ethoxy]phenyl]methyl]-2,4-thiazolidinedione and their salts
IL193670A0 (en) A new crystalline form g of (5s)-5-[4-(5-chloro-pyridin-2-yloxy)-piperidine-1-sulfonyl-methyl]-5-methyl-imidazolidine-2,4-dione (i) and intermediates thereof
BRPI0921596A2 (pt) Compostos de 4-[2-(2-fluorofenoximetil) fenil] piperidina
IL279186A (en) Use of 5-[[4-[2-[5-acetylpyridin-2-yl]ethoxy]benzyl]-1, 3-thiazolidine-2, 4-dione and their salts
HRP20130004T8 (en) 4-substituted phenoxyphenylacetic acid derivatives
ZA201108707B (en) Trans-4[(5s)-5[[[3,5-bis(trifluoromethyl)phenyl]methyl](2-methyl-2h-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1h-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid
PL3548026T3 (pl) 5-[[4-[2-[5-(1-hydroksyetylo)pirydyn-2-ylo]etoksy]fenylo]metylo]-1,3-tiazolidyno-2,4-dion do leczenia niealkoholowej stłuszczeniowej choroby wątroby
IL200959A0 (en) Liquid formulations of salts of 4-[2-(4-methylphenylfanyl)phenyl]piperidine
CY2200159T2 (el) 2-ν-{5-[[4-[2-μεθυλ-2-πυριδινυλαμινο)αιθοξυ]φαινυλ]μεθυλ]-2-4-θειαζολιδινοδιονο} βουτανιοδιοϊκο οξυ, μεθοδοι παρασκευης και συνθεσεις με μηλεϊνικη ροζιγλιταζονη
IL188175A0 (en) 2-n-(5-[[4-(2-methyl-2-pyridinylamino)ethoxy] phenyl] methyl]-2,4-thiazolidinedione)butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
ZA200809383B (en) Salts of n-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl] amino]methyl]phenyl]-2E-2propenamide
IL212463A0 (en) Compositions comprising 4-(2-(5-bromo-4-(l-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio)acetamido-3-chlorobenzoic acid and pharmaceutically acceptable salts thereof
WO2008105326A1 (ja) ２－イミノ－４－チアゾリジノン誘導体及び２，４－チアゾリジンジオン誘導体の製造方法
HK40049678A (en) Use of 5-[[4-[2-[5-acetylpyridin-2-yl]ethoxy]benzyl]-1,3-thiazolidine-2,4-dione and its salts

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)